MIMS Must Have's
A review of some of the most important safety related changes, new indications and formulations changes we have made to the MIMS Product Information this month.

Click on below to access: 

• Important New Products
  • Erivedge
  • GyMiso
  • Jakavi
  • Priligy
  • Zaltrap
  • Zario
• Safety-Related Changes
• Full Update Medications

Latest News

myDr
Bread in the diet...more

Bunions...more

Alzheimer's disease...more

Osteoporosis risk factors...more

Consumer health and medical news and information from MIMS. Providing quality Australian patient information you can trust. myDr.com.au

Medical Observer
Psychotropic meds reduction program in Tas...more

Minimising antibiotic resistance risk...more

Minor elevated diabetes risk with statin use...more

Death risk high in type 2 diabetes youth...more

For regular medical news, features and lifestyle content sign-up to receive Medical Observer’s e-newsletter at: medicalobserver.com.au

From the Desk of the Managing Editor

The new eMIMS - your first source of digital medicines knowledge - it's simple

eMIMS gets  a makeover and looks and feels years younger. Meet eMIMSCloud and soon eMIMSDesktop.
It was 17 year ago that eMIMS was launched and in those years it has become the most used and loved resource for many MIMS customers from all areas of healthcare...more